Improving Patient Assessment After Acute Kidney Injury (AKI)
Recruiting
Observational Study
Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University of Nottingham · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to improve patient care after acute kidney injury (AKI). It has three related parts. The main questions it aims to answer are:
1. Is creatinine or cystatin a more reliable assessment of kidney function after AKI?
2. What are the experiences of patients after AKI?
3. What interventions should be recommended to improve assessment and support of patients after AKI?…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Observational study workstream
* Age 18-85 years
* AKI stage 2 or 3 during hospital admission OR AKI stage 1 of at least 7 days duration during hospital admission
* 60-90 days after peak creatinine Qualitative interview workstream
* Age 18-85 years
* AKI during hospital admissi…
Contacts